Jazz Pharmaceuticals PLC at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm one of the biotech analysts at JPMorgan. And we're continuing the 2020 Health Care Conference this morning with Jazz Pharmaceuticals. Speaking for Jazz is going to be the company's Chairman and CEO, Bruce Cozadd. And right after this, we're going to go across the hall to the Georgian room for a breakout session where we're going to do some Q&A. You can follow me over there. Looking forward to hearing some interesting updates from Jazz.
Great. Good morning, everyone. So I'm thrilled to be back for my 29th consecutive JPMorgan Conference, one of my favorite weeks of every year. And I've the distinct privilege of providing an update on Jazz Pharmaceuticals progress. And I have to say in 2019, thanks to the passion, the innovation, the integrity, the collaboration and the pursuit of excellence on the part of our 1,560 dedicated and talented employees, we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |